Literature DB >> 6826322

The visual evoked potential in glaucoma and ocular hypertension: effects of check size, field size, and stimulation rate.

V L Towle, A Moskowitz, S Sokol, B Schwartz.   

Abstract

In order to determine the optimum stimulus conditions for the detection of optic nerve damage due to glaucoma and ocular hypertension, checkerboard pattern reversal visual evoked potentials (VEPs) were recorded from 20 glaucoma patients, 20 ocular hypertensive patients, and 20 age-matched normals. Two check sizes (12' and 48'), two field sizes (14 degrees and 28 degrees), and two alternation rates (1.9 and 7.5 alt/sec) were used. All subjects had visual acuities of 20/40 or better in each eye and equal pupils of 2 to 5 mm diameter. The largest number of VEP abnormalities were found with large checks (48') reversing at a fast rate (7.5 alt/sec). After correcting for the effects of age, visual acuity, and pupil size, 16 of 30 eyes with glaucomatous visual field defects had abnormally long VEP latencies under this condition (beyond the 99% confidence limit of the normal subjects). Nine of 40 ocular hypertensive eyes also had abnormally long latencies. Increased pattern VEP latency was significantly correlated with both the severity and location of visual field defects and the degree of cupping and pallor of the optic disc. VEP latency was not significantly related to intraocular pressure.

Entities:  

Mesh:

Year:  1983        PMID: 6826322

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

1.  Steady-state visual evoked cortical potentials from stimulation of visual field quadrants. Optimizing pattern variables for the size of the field to be investigated.

Authors:  M Bradnam; D Keating; D Montgomery; A Evans; B Damato; A Cluckie
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

2.  Effect of eccentricity on pattern-pulse multifocal VEP.

Authors:  Alexander I Klistorner; Stuart L Graham
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

3.  The effects of glaucoma on the latency of the multifocal visual evoked potential.

Authors:  S L Graham
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

4.  Color pattern-reversal visual evoked potential in eyes with ocular hypertension and primary open-angle glaucoma.

Authors:  Y H Shih; Z J Huang; C E Chang
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

5.  Neural conduction in the visual pathways in ocular hypertension and glaucoma.

Authors:  V Parisi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

6.  Short-duration transient visual evoked potentials and color reflectivity discretization analysis in glaucoma patients and suspects.

Authors:  Michael Waisbourd; Rebekah H Gensure; Ardalan Aminlari; Sonya B Shah; Nitasha Khanna; Neil Sood; Jeanne Molineaux; Alberto Gonzalez; Jonathan S Myers; L Jay Katz
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

7.  The role of the multifocal visual evoked potential (mfVEP) latency in understanding optic nerve and retinal diseases.

Authors:  Donald C Hood; John Y Chen; E Bo Yang; Chris Rodarte; Adam S Wenick; Tomas M Grippo; Jeffrey G Odel; Robert Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Repeatability of short-duration transient visual evoked potentials in normal subjects.

Authors:  Celso Tello; Carlos Gustavo V De Moraes; Tiago S Prata; Peter Derr; Jayson Patel; John Siegfried; Jeffrey M Liebmann; Robert Ritch
Journal:  Doc Ophthalmol       Date:  2010-01-29       Impact factor: 2.379

9.  PRBS-determined temporal frequency characteristics of VEP in glaucoma.

Authors:  Keiko Momose; Motohiro Kiyosawa; Nobuyuki Nemoto; Hiroshi Mori; Manabu Mochizuki; Joseph Jy-Haw Yu
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

10.  The pattern-evoked electroretinogram (PERG): age-related alterations and changes in glaucoma.

Authors:  M Korth; F Horn; B Storck; J Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.